Katie Couric on Truth, Trust, and Women's Health

Mary Claire explains that the WHI's conclusion that HRT does not help heart disease was driven by enrolling women with an average age of 63, many already with atherosclerosis. In contrast, newer trials and re-analyses show that if estrogen is given during the 'critical window'—within 10 years of the final menstrual period and before age 60—it reduces coronary heart disease and all-cause mortality. This is consistent with the 'timing hypothesis.' She stresses that doctors must move away from the blanket 'HRT is bad' message derived from the WHI and instead apply this age- and time-dependent guidance.

Mary Claire presents Duavee as a breakthrough for the large population of women historically denied HRT after breast cancer. She describes tamoxifen, the traditional SERM, as often causing hot flashes and joint pain, while Duavee actually treats those symptoms. She mentions that early studies in stage zero (DCIS) patients show decreased recurrence, and she is comfortable using it in high-risk patients after thorough counseling. She contrasts it with vaginal estrogen, which is now considered safe even in estrogen-receptor-positive breast cancer, but many oncologists still refuse it. The protocol is to discuss the risk-benefit and offer Duavee as a compromise.

When Katie asks about vaginal estrogen, Mary Claire confirms that it is now considered safe, citing modern guidelines. She notes that the fear persists because many clinicians still reference outdated WHI fears, but that the estrogen doses used vaginally are about 1/10th to 1/100th the systemic levels, insufficient to stimulate tumor growth. She encourages women to bring this up with their doctors and seek practitioners who stay current.

Mary Claire explains that medicine is becoming more cautious with PPIs due to the rise in esophageal cancer and possible masking effects. She notes that in her own family, treating H. pylori resolved reflux. She now emphasizes aggressive screening and root cause treatment: 'instead of addressing like for me I had H. pylori and so once we got that managed I never I rarely rarely have reflux anymore.' This approach represents a shift away from simply suppressing acid.

Mary Claire notes that after the Andrea Yates tragedy, Texas mandated routine screening, and she believes it spread nationally. She shared her own intrusive thoughts, which she did not act on, to normalize the experience and emphasize that it's due to the massive estrogen drop. Katie also shared her fears. This screening is now standard in Texas, but they hope it's universal.

Katie highlights that women are more likely to die in car crashes than men because seat belts, airbags, and other safety features were optimized for male bodies. She notes that only recently did regulators and manufacturers introduce dummies with breasts and adjusted weight distributions. This example is used as a metaphor for the broader pattern of women's health being ignored in medical research, drug development, and safety testing, a theme central to the documentary she is producing.

Mary Claire recounts that she was a resident near the area when the tragedy occurred, and remembers the horror. She notes that both she and Katie experienced intrusive thoughts after childbirth (Mary Claire with her daughter in the bath, Katie fearing leaving baby on the road), which they attribute to the massive estrogen drop postpartum. She credits the case with pushing through mandatory Edinburgh Postnatal Depression Scale screening at every postpartum check, a policy that likely caught many cases early. Katie adds that it's another example of medicine ignoring a female-specific issue, contrasting the rush to develop Viagra with the neglect of maternal mental health.

Katie frames this statistic as part of the broader documentary she's developing on hormones and women's health. She expresses shock that so little research dollars go to women-specific aspects, linking it to the underfunding of menopause and female biology overall. Mary Claire agrees that the drop in estrogen after menopause likely accelerates brain changes, and that more funding is needed to understand this connection. The discussion serves as another data point in the argument that women's health is systematically under-prioritized.